• Sheraton New York Times Square Hotel (map)
  • 811 7th Avenue
  • New York, NY, 10019
  • United States

Session Chairs:  Dario A. Vignali, University of Pittsburgh, Pittsburgh, PA, and E. John Wherry, University of Pennsylvania, Philadelphia, PA

1:30 p.m.  Dario A. Vignali, University of Pittsburgh, Pittsburgh, PA
Targeting T regs in tumors

2:10 p.m.  E. John Wherry, University of Pennsylvania, Philadelphia, PA
Molecular basis of T cell exhaustion: Insights for immunotherapy

2:40 p.m.  Darin Salloum, Memorial Sloan-Kettering Cancer Center, New York, NY
HVEM (TNFRSF14) tumor suppressor in immune therapies of follicular lymphoma*

2:55 p.m.  Refreshment Break

3:25 p.m.  Susan Kaech, Yale University School of Medicine, New Haven, CT
Anti-tumor T cells: You are what you eat

3:55 p.m.  Greg M. Delgoffe, University of Pittsburgh Cancer Institute, Pittsburgh, PA
Identifying and overcoming metabolic checkpoints to anti-tumor immunity

4:25 p.m.  Stephen Willingham, Corvus Pharmaceuticals, Burlingame, CA
CPI-444: A potent and selective inhibitor of A2AR induces anti-tumor responses alone and in combination with anti-PD-L1 in preclinical and clinical studies*

* Proffered presentation